A randomised, double-blind, placebo-controlled study to determine the efficacy of soluble beta-1,3/1,6-glucan in chronic foot ulcers in diabetes

To determine the effect of topically administered soluble beta-1,3/1,6-glucan (SBG) compared with that of placebo in chronic foot ulcers in diabetes.